Nanog Maintains Stemness of Lkb1‐deficient Lung Adenocarcinoma and Prevents Gastric Differentiation

Xinyuan Tong,Yueqing Chen,Xinsheng Zhu,Yi Ye,Yun Xue,Rui Wang,Yijun Gao,Wenjing Zhang,Weiqiang Gao,Lei Xiao,Haiquan Chen,Peng Zhang,Hongbin Ji

DOI: https://doi.org/10.15252/emmm.202012627

2021-01-01

EMBO Molecular Medicine

Abstract:Correction to: EMBO Mol Med (2021) 13: e12627. DOI https://doi.org/10.15252/emmm.202012627 ¦ Published online 13 January 2021 The authors were alerted to duplicated images between Figures 2A and 3G, 2B and 4I, and 4B and 4I. The authors state that the human IMA HE stainings in Figure 2A and Figure 3G are from the same sample. The legend of Figure 3G is amended to indicate that the sample is also shown in Figure 2A. The 10x HE image in Figure 2B had been incorrectly displayed in the 40x HE image in Figure 4I. The authors state that they used the incorrect photograph from the KLN IMA vehicle treatment group in Figure 2B. The authors have identified the correct low-magnification image that corresponds to the magnification currently displayed in Figure 2B and herewith retract and replace this panel. The bottom middle panel of NICD immunostaining for KLN IMA in Figure 4B displayed an image from a similar field of the NICD immunostaining for KLN IMA (vehicle group) in Figure 4I. The authors state that these two photographs were mislabeled during the acquisition process. The authors have identified the correct image for NICD immunostaining for KLN IMA in Figure 4B in the original data and herewith retract and replace this panel. Lastly, the authors note that the labeling in Figure 4J had previously been inverted and this is herewith corrected. The authors state that these changes do not affect the interpretation of the data or the conclusions of the study. The authors apologize for this oversight and for any inconvenience it may have caused. Figure 2B. Original. Figure 2B. Corrected. Figure 4B. Original. Figure 4B. Corrected. Figure 4J. Original. Figure 4J. Corrected.